Literature DB >> 17578651

Polyamine contents in current foods: a basis for polyamine reduced diet and a study of its long term observance and tolerance in prostate carcinoma patients.

B G Cipolla1, R Havouis, J P Moulinoux.   

Abstract

Polyamine contents were assessed by mass spectrometry in 233 current foods and beverages. In order to reduce gut polyamine uptake, a polyamine reduced diet (PRD) and partial intermittent intestinal tract decontamination (PIITD) with neomycin or nifuroxazide was proposed as nutritional therapy to 33 prostate carcinoma patients, 30 of whom with hormone refractory prostate cancer (HRPC). Mean PRD observance was 22 +/- 19 (median: 16; range: 3-72) months. 10, 8 and 3 patients were respectively on PRD for more than 30, 36 and 64 months. No diet toxicity was observed. 8 patients had moderate intestinal intolerance due to PIITD which was interrupted. No significant differences in body weight, blood counts or serum protein levels were observed during the follow-up of patients under PRD. Performance status and pain scores were relatively stable during the trial with improved pain scores at 6 months. A PRD associated with intermittent PIITD is a safe and well observed nutritional regimen and long term observance is possible.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578651     DOI: 10.1007/s00726-007-0524-1

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  23 in total

1.  Dairy Intake in 2 American Adult Cohorts Associates with Novel and Known Targeted and Nontargeted Circulating Metabolites.

Authors:  Adela Hruby; Courtney Dennis; Paul F Jacques
Journal:  J Nutr       Date:  2020-05-01       Impact factor: 4.798

Review 2.  Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.

Authors:  Athanassios P Kyritsis; Melissa L Bondy; Victor A Levin
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

3.  Fentanyl-induced hyperalgesia and analgesic tolerance in male rats: common underlying mechanisms and prevention by a polyamine deficient diet.

Authors:  Emilie Laboureyras; Meric Ben Boujema; Annie Mauborgne; John Simmers; Michel Pohl; Guy Simonnet
Journal:  Neuropsychopharmacology       Date:  2021-10-07       Impact factor: 7.853

Review 4.  Pharmacological potential of biogenic amine-polyamine interactions beyond neurotransmission.

Authors:  F Sánchez-Jiménez; M V Ruiz-Pérez; J L Urdiales; M A Medina
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

5.  Polyamines: total daily intake in adolescents compared to the intake estimated from the Swedish Nutrition Recommendations Objectified (SNO).

Authors:  Mohamed Atiya Ali; Eric Poortvliet; Roger Strömberg; Agneta Yngve
Journal:  Food Nutr Res       Date:  2011-01-14       Impact factor: 3.894

6.  Polyamines in foods: development of a food database.

Authors:  Mohamed Atiya Ali; Eric Poortvliet; Roger Strömberg; Agneta Yngve
Journal:  Food Nutr Res       Date:  2011-01-14       Impact factor: 3.894

7.  Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production.

Authors:  Mitsuharu Matsumoto; Shin Kurihara; Ryoko Kibe; Hisashi Ashida; Yoshimi Benno
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

8.  Catalytically active bovine serum amine oxidase bound to fluorescent and magnetically drivable nanoparticles.

Authors:  Giulietta Sinigaglia; Massimiliano Magro; Giovanni Miotto; Sara Cardillo; Enzo Agostinelli; Radek Zboril; Eris Bidollari; Fabio Vianello
Journal:  Int J Nanomedicine       Date:  2012-05-03

Review 9.  Polyamines: Functions, Metabolism, and Role in Human Disease Management.

Authors:  Narashans Alok Sagar; Swarnava Tarafdar; Surbhi Agarwal; Ayon Tarafdar; Sunil Sharma
Journal:  Med Sci (Basel)       Date:  2021-06-09

10.  Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas.

Authors:  K P Raj; J A Zell; C L Rock; C E McLaren; C Zoumas-Morse; E W Gerner; F L Meyskens
Journal:  Br J Cancer       Date:  2013-01-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.